C4 Therapeutics, Inc.
CCCC
$2.69
-$0.12-4.27%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -24.94% | -18.76% | -16.69% | -3.46% | 18.04% |
| Total Receivables | -36.74% | 84.92% | -40.97% | -73.71% | 1,968.20% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 16.45% | -25.62% | 20.75% | 70.98% | 9.51% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -24.29% | -18.59% | -16.83% | -4.95% | 22.15% |
|
|
|||||
| Total Current Assets | -24.29% | -18.59% | -16.83% | -4.95% | 22.15% |
| Net Property, Plant & Equipment | -27.96% | -11.28% | -11.24% | -10.85% | -10.21% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -58.00% | -40.25% | -30.73% | -1.10% | 30.63% |
| Total Assets | -29.40% | -22.19% | -19.79% | -7.13% | 12.93% |
|
|
|||||
| Total Accounts Payable | -11.37% | 142.72% | -58.10% | -8.16% | 17.87% |
| Total Accrued Expenses | -29.87% | 34.41% | 0.04% | 12.95% | 1.49% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.37% | 10.43% | 10.53% | 10.63% | 10.71% |
| Total Finance Division Other Current Liabilities | -16.41% | -37.77% | -37.06% | -0.15% | 114.38% |
| Total Other Current Liabilities | -16.41% | -37.77% | -37.06% | -0.15% | 114.38% |
| Total Current Liabilities | -16.97% | -17.98% | -25.81% | 5.64% | 43.02% |
|
|
|||||
| Total Current Liabilities | -16.97% | -17.98% | -25.81% | 5.64% | 43.02% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -10.11% | -9.64% | -9.19% | -8.78% | -8.39% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -30.58% | 25.07% | 21.30% | 30.45% | 45.99% |
| Total Liabilities | -16.73% | -8.63% | -11.21% | 2.52% | 14.03% |
|
|
|||||
| Common Stock & APIC | 3.71% | 4.64% | 4.87% | 9.68% | 18.40% |
| Retained Earnings | -19.88% | -19.42% | -18.55% | -19.93% | -21.37% |
| Treasury Stock & Other | -80.88% | 93.18% | 111.32% | 141.73% | 150.33% |
| Total Common Equity | -36.37% | -29.55% | -24.45% | -12.24% | 12.33% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -36.37% | -29.55% | -24.45% | -12.24% | 12.33% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -36.37% | -29.55% | -24.45% | -12.24% | 12.33% |
|
|
|||||